These results raise the question whether the alterations in serum chemerin levels and hepatic chemerin and Cmklr1 expression found in rodent models of NAFLD [7], [12], [14] are causally involved in the development and/or progression of this disease. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.